18. Spinocerebellar degeneration Clinical trials / Disease details
Clinical trials : 76 / Drugs : 98 - (DrugBank : 31) / Drug target genes : 44 - Drug target pathways : 65
| Previous names | - | ||
|---|---|---|---|
| Other names | SCD; | ||
| Disease group | Neuromuscular diseases | ||
| Related info (in Japanese) | - | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 11-27-80. spinocerebellar degeneration; SCD | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 18-1. | Spinocerebellar ataxia type I;SCA1; | ||
| 18-2. | Spinocerebellar ataxia type II;SCA2; | ||
| 18-3. | Spinocerebellar ataxia type III;SCA3;Machado-Joseph disease; | ||
| 18-4. | Spinocerebellar ataxia type VI;SCA6; | ||
| 18-5. | Spinocerebellar ataxia type VII;SCA7; | ||
| 18-6. | Spinocerebellar ataxia type X;SCA10; | ||
| 18-7. | Spinocerebellar ataxia type XII;SCA12; | ||
| 18-8. | Dentatorubural pallidoluysian atrophy;Dentatorubropallidoluysial atrophy;DRPLA;Naito-Koyanagi disease; | ||
| 18-9. | Friedreich ataxia;FRDA; | ||
| 18-10. | Ataxia with vitamin E deficiency;AVED; | ||
| 18-11. | Early-onset ataxia with ocular motor ataxia and hypoalbuminemia;EOAH; | ||